P881: CDK7 CONTRIBUTES TO METABOLIC REPROGRAMMING IN MM CELLS THROUGH C-MYC MEDIATED TRANSCRIPTIONAL CONTROL OF GLYCOLYTIC GENES

• Y. Yao,
• J. Fong Ng,
• W. D. Park,
• D. Gramegna,
• A. Samur,
• M. Samur,
• E. Morelli,
• M. Chesi,
• C. Mitsiades,
• K. C. Anderson,
• C. Lin,
• N. Munshi,
• M. Fulciniti

Affiliations

Y. Yao

1 Dana Farber Cancer Institute, Boston, United States of America

J. Fong Ng

1 Dana Farber Cancer Institute, Boston, United States of America

W. D. Park

3 Baylor College of Medicine, Houston

D. Gramegna

1 Dana Farber Cancer Institute, Boston, United States of America

A. Samur

1 Dana Farber Cancer Institute, Boston, United States of America

M. Samur

1 Dana Farber Cancer Institute, Boston, United States of America

E. Morelli

1 Dana Farber Cancer Institute, Boston, United States of America

M. Chesi

4 Mayo Clinic, Scottsdale, United States of America

C. Mitsiades

1 Dana Farber Cancer Institute, Boston, United States of America

K. C. Anderson

1 Dana Farber Cancer Institute, Boston, United States of America

C. Lin

3 Baylor College of Medicine, Houston

N. Munshi

1 Dana Farber Cancer Institute, Boston, United States of America

M. Fulciniti

1 Dana Farber Cancer Institute, Boston, United States of America